Nextrials' Prism for Healthcare and Clinical Trial Data Management Adds Support for Google Chrome

Nextrials' Prism for Healthcare and Clinical Trial Data Management Adds Support for Google Chrome
Wide Browser Selection Gives Prism More Flexibility for Use with Legacy Systems or Today's Newest Platforms

SAN RAMON, Calif.--(BUSINESS WIRE)--Nextrials, Inc. (www.nextrials.com), a leader in clinical research software and services, today announced that its electronic data capture (EDC) and clinical trial data management platform, PrismTM, is now compatible with the Google ChromeTM browser. Already available for use with Apple®'s Safari®, Microsoft® Internet Explorer® and Mozilla® Firefox®, Prism's compatibility with Google Chrome means more choices for customers who may be upgrading corporate systems with newer hardware or mobile devices.

"Although many of our customers are still using legacy systems, there is an increasing number that are migrating to newer hardware and mobile platforms like the iPad"
."Although many of our customers are still using legacy systems, there is an increasing number that are migrating to newer hardware and mobile platforms like the iPad," noted James Rogers, CEO and co-founder of Nextrials. "We place a high priority on adding features, functionality and compatibility, such as integration with leading electronic health records platforms, to keep Prism user-friendly and easier to deploy."

Google Chrome is a free, cross-platform web browser released in 2008. Available for PC and Mac, it features built-in security protection against malware and phishing, an incognito browsing functionality and a new JavaScript engine to speed up today's web applications. Users typically report that web-based applications like Prism run faster using Chrome.

Nextrials' award-winning Prism melds sophisticated clinical trial management functionality with EDC in a single, integrated package. By receiving a constant flow of data, Prism enables sponsors and sites to fully utilize real-time integration of disparate information and data sources, such as a hospital's EHR or patient records, to better provide a continuum of care for patients enrolled in clinical trials. Prism is the only platform to be successfully used in a multi-site study where real-time, live patient data was collected and shared by what had previously been two disparate data management platforms.

About Nextrials, Inc.

Founded by pharmaceutical researchers in 1999, Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. PrismTM, its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,500 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com or call 925-355-3000.


Contacts
VOXUS, Inc.
Rachel V. Berry, 253-853-5151, ext. 223
[email protected]

Suggested Articles

Insitro picked up $143 million to build out its technology, pursue new targets and advance treatments for genetically defined patient groups.

Generation Bio filed for a $215 million IPO to advance a pair of gene therapies for liver disease and push one of them into the clinic.

The IPO will push Avidity's lead muscle disorder program through IND-enabling studies and into the clinic in 2021.